spot_img

Biofarm

Biofarm, one of the most important drug producers in Romania, targets a 16% increase in turnover in 2022

By rbj Biofarm, one of the most important drug producers in Romania, estimates a 16% increase in turnover for this year, after recording a value of 239 million lei and an EBITDA of approximately 2021 in 2021 82 million lei,...
- Advertisement -spot_img

Latest News

The Board of the National Bank of Romania decided to keep the monetary policy rate at 6.50 percent per annum

Bucharest, February 17, 2026 - RBJ - In its meeting of February 17, 2026, the Board of the National...
- Advertisement -spot_img